Response augmentation and blockade in cholinergic neuromuscular tissues.
D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology; D000110:Acetylcholinesterase / Q000378:metabolism; D000818:Animals; D001665:Binding Sites; D002800:Cholinesterase Inhibitors; D004558:Electric Stimulation; D004594:Electrophysiology; D004952:Esters; D005702:Galantamine / Q000494:pharmacology; D050356:Lipid Metabolism; D051379:Mice; D008959:Models, Neurological; D008968:Molecular Conformation; D009469:Neuromuscular Junction / Q000166:cytology / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism / Q000502:physiology*; D018377:Neurotransmitter Agents / Q000502:physiology; D010648:Phenylacetates / Q000494:pharmacology; D051381:Rats; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship; D009435:Synaptic Transmission / Q000187:drug effects; D014118:Toxins, Biological / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D004952:Esters; D018377:Neurotransmitter Agents; D010648:Phenylacetates; D014118:Toxins, Biological; D005702:Galantamine; D000110:Acetylcholinesterase; D000109:Acetylcholine